Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02593240
Other study ID # 11768
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 2015
Est. completion date March 2018

Study information

Verified date August 2020
Source Tufts University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Worksites offer attractive locations for reducing the national prevalence of overweight and obesity. Interventions that are both effective and sustainable for producing long-term changes in health and employee wellness are urgently needed. In an 18-month worksite randomized controlled trial in 12 worksites, this study will test two lifestyle approaches designed to facilitate behavior modification for achieving long-term improvements in health and quality of life. Worksites randomized to the immediate intervention arm will receive the two on-site wellness programs and the randomized control sites will participate in outcomes assessments for the initial 6-month period, after which participants will receive vouchers to participate in the program of their choice. The primary focus of the worksite wellness study is to identify ways to improve health-related quality of life, with a particular focus on a decrease in cardiometabolic risk factors, including weight, improved weight-related wellness, and improved energy level in work and life. The two interventions will be separately tested against the control condition in intention-to-treat models and with a completers analysis.


Recruitment information / eligibility

Status Completed
Enrollment 554
Est. completion date March 2018
Est. primary completion date March 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 21 Years and older
Eligibility Inclusion Criteria:

1. Willingness to sign an informed consent form

2. Willingness to provide release from his/her physician before starting the intervention program-a requirement for each of the 3 wellness programs

3. Willingness to provide email identification (ID) and contact information to the commercial program facilitators to receive program materials and other feedback related to program progress

4. Willingness to complete outcome assessments and self-monitoring in order to track intervention effectiveness

5. BMI = 20 kg/m2 and < 50 kg/m2 at screening, if participant opts into the HPI arm

6. BMI = 25 kg/m2 and < 50 kg/m2 at screening, if participant opts into the weight loss arm

Exclusion Criteria:

1. Employees who are temporary contract workers or employees who work remotely most of the time

2. < 21 years of age

3. Participation in a weight loss program or intensive wellbeing program at time of enrollment

4. Pregnant or lactating (per self-reports, now or intended during study)

5. Prior weight loss surgery or a medical complication that would prevent full participation

6. Multiple severe dietary intolerances (e.g. gluten combined with dairy or meat) which would reduce intervention adherence

7. Non-English speaking

8. Individuals who have lost > 15 pounds in the past 6 months

9. Mobility limitations (inhibiting the ability to stand on one's own or get on and off of the scale)

10. Major diseases including active cancer or cardiovascular disease

11. BMI < 25 kg/m2 or = 50 kg/m2 at screening, for those that opt-in to the weight-loss group

12. BMI <20 kg/m2 or = 50 kg/m2 at screening, for those that opt-in to the HPI group

For those interested in the weight loss intervention, additional exclusion criteria are as follows:

13. Any condition that influences the ability to absorb food (e.g. inflammatory bowel disease or celiac disease)

14. Very active individuals (> 2 hours/day or >14 hours/week of vigorous activity).

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
The iDiet® (also called Healthy Weight for Living when used as a not-for-profit intervention) with Food
The intensive iDiet® group behavioral weight loss program will be delivered in person at the worksite or by videoconference and with support of the program's web platform. This intervention will be delivered by trained group leaders and will initially include weekly 1-hour support and education meetings of 20 participants/group with a message board for group communication and individual communication with the group leader. Over time support will be provided online rather than in live meetings. The intervention involves a weight loss behavioral program with particular emphasis on hunger reduction and craving control for both weight loss and prevention of weight regain. Half of the participants per worksite receiving the iDiet® intervention will be randomized to receive commercial dried food products (partial supply) from Yevo Intl., which are designed to help with weight control and health.
The iDiet® (also called Healthy Weight for Living when used as a not-for-profit intervention) with Voucher
The intensive iDiet® group behavioral weight loss program delivered in person at the worksite or by videoconference and with support of the program's web platform. This intervention will be delivered by trained group leaders and will initially include weekly 1-hour support and education meetings of 20 participants/group with a message board for group communication and individual communication with the group leader. Over time support will be provided online rather than in live meetings. The intervention involves a weight loss behavioral program with particular emphasis on hunger reduction and craving control for both weight loss and prevention of weight regain. Half of the participants per worksite receiving the Diet® intervention will be randomized to receive gift cards monthly for the first 6 months to purchase foods at their local grocery store (partial costs).
Human Performance Institute©
The Human Performance Institute© (HPI) training workshop is a comprehensive individual development training program that focuses on the concept of energy management. The primary aim of this program is to help individuals develop attitudes, habits, and behaviors that increase their levels of daily energy, life satisfaction, and overall functioning. The course is delivered at an off-site location over 2.5 days, by 3 coaches, in a group format of 25 - 32 participants (with employees from more than one worksite per group).

Locations

Country Name City State
United States Tufts University Human Nutrition Research Center on Aging Boston Massachusetts

Sponsors (1)

Lead Sponsor Collaborator
Tufts University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Weight (iDiet/Healthy Weight for Living arms) Fasted measurements of weight obtained in duplicate to ±0.1 kg at baseline, 6, 12, and 18 months using the TANITA TBF-300A. 1.5 years
Primary Quality of Life (HPI arm) Assessed by the RAND Short Form 36 Health Survey (SF-36) at baseline, 6, 12, and 18 months. 1.5 years
Secondary Blood pressure Systolic and diastolic blood pressure (mm Hg) measured to the nearest 1 mm Hg at baseline, 6, 12, and 18 months using a validated automated monitor (3 fasted measurements, 5 minutes apart, after 5 minutes of quiet sitting). 1.5 years
Secondary Cholesterol Total cholesterol, high-density lipoprotein, and low-density lipoprotein measured at baseline, 6, 12, and 18 months using the Alere Cholestech LDX® System, which requires 40 microliters of blood (fasted lipid panel). 1.5 years
Secondary Triglycerides Triglycerides measured at baseline, 6, 12, and 18 months using the Alere Cholestech LDX® System (fasted lipid panel). 1.5 years
Secondary Glucose Fasting blood glucose measured at baseline, 6, 12, and 18 months using the Alere Cholestech LDX® System. 1.5 years
Secondary Hemoglobin A1c HbA1c measured at baseline, 6, 12, and 18 months using the Siemens DCA Vantage, which requires 1 microliter of blood (fasted measurement). 1.5 years
Secondary Eating behavior (Food Preferences) Assessed by the Food Preferences Questionnaire (self-administered) at baseline, 6, 12, and 18 months. 1.5 years
Secondary Eating behavior (Three-Factor Eating) Assessed by the Three-Factor Eating Questionnaire (self-administered) at baseline, 6, 12, and 18 months. 1.5 years
Secondary Eating behavior (Food Cravings) Assessed by the Food Cravings Questionnaire - Trait (self-administered) at baseline, 6, 12, and 18 months. 1.5 years
Secondary Depression Assessed by the Center for Epidemiological Studies Depression Scale (self-administered) at baseline, 6, 12, and 18 months. 1.5 years
Secondary Mood Assessed by the Profile of Mood States (self-administered) at baseline, 6, 12, and 18 months. Variables include anger-hostility, depression-dejection, fatigue-inertia, and vigor-activity. 1.5 years
Secondary Physical Activity Assessed by the International Physical Activity Questionnaire (self-administered) at baseline, 6, 12, and 18 months. 1.5 years
Secondary Well-being Assessed by the Ryff Purpose in Life scale (self-administered) at baseline, 6, 12, and 18 months. 1.5 years
Secondary Productivity Assessed by the Work Productivity and Impairment scale (self-administered) at baseline, 6, 12, and 18 months. 1.5 years
Secondary Sleep Assessed by the Medical Outcomes Study Sleep Questionnaire (self-administered) at baseline, 6, 12, and 18 months. 1.5 years
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2